Procter & Gamble Health share news, announcements and annual reports
NSE: PGHLBSE: 500126Pharmaceuticals & BiotechnologySmall Cap
Procter & Gamble Health Limited · Formerly Merck · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jan 1982 on BSE, Apr 1996 on NSE
Last close ₹5,670.50up ₹157.00 (2.85%)BSE ₹5,684.40
Share price at the NSE close on 30 Oct 2026. Previous close ₹5,513.50.
30 Oct: open ₹5,501.50, high ₹5,731.00, low ₹5,442.50
52-week range of traded prices to 30 Oct 2026
₹4,707.00Low, 6 Apr 2026₹6,975.00High, 15 Jul 2026
- Next results date: the board meets on 2 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹9,413 Cr585th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 26.37
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 17.94
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 3.62%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 67.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 84.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 13,61957.6% delivered
Procter & Gamble Health board meetings
113 filed, newest first. Page 2 of 3.
Aug 2019
8 Aug · Board meeting
Jul 2019
May 2019
10 May · Board meeting
10 May · Board meeting
Apr 2019
2 Apr · Board meeting
Feb 2019
27 Feb · Board meeting
Oct 2018
19 Oct · Board meeting
Jul 2018
19 Jul · Board meeting
Apr 2018
27 Apr · Board meeting
Feb 2018
Oct 2017
Jul 2017
Apr 2017
Feb 2017
28 Feb · Board meeting
Jan 2017
Oct 2016
Jul 2016
Apr 2016
Feb 2016
Dec 2015
21 Dec · Board meeting
Oct 2015
Jul 2015
Apr 2015
Feb 2015
5 Feb · Board meeting
Jan 2015
Oct 2014
13 Oct · Board meeting
To consider and approve the unaudited financial results for the quarter ended September 30, 2014.
Jul 2014
23 Jul · Board meeting
To consider and approve the unaudited financial results for the quarter ended June 30, 2014.
Mar 2014
Jan 2014
Oct 2013
3 Oct · Board meeting
To consider and approve the Unaudited Financial Results for the quarter ended September 30, 2013.
Jun 2013
27 Jun · Board meeting
To Consider and approve the Un-audited Financial Results for the quarter ended June 30, 2013.
Apr 2013
8 Apr · Board meeting
To consider and approve the Un-audited Financial Results for the quarter ended March 31, 2013.
Oct 2012
22 Oct · Board meeting
To consider and approve the Unaudited Financial Results for the quarter ended September 30, 2012.
Jul 2012
3 Jul · Board meeting
To consider and approve the Un-audited Financial Results for the second quarter and half year ended June 30, 2012.
Apr 2012
10 Apr · Board meeting
To consider and approve the Un-audited Financial Results for the quarter ended March 31, 2012.
Feb 2012
9 Feb · Board meeting
To consider and approve the Audited Financial Results for the year ended December 31, 2011.
Jan 2012
20 Jan · Board meeting
To take on record the Audited Financial Results for the year ended December 31, 2011.
Oct 2011
5 Oct · Board meeting
To take on record the Unaudited Financial Results for the thrid quarter ended September 30, 2011.
Jul 2011
13 Jul · Board meeting
To take on record the Un-audited Financial Results for the second quarter and half year ended June 30, 2011.
Apr 2011
8 Apr · Board meeting
To take on record the Un-audited Financial Results for the first quarter ended March 31, 2011.
Jan 2011
21 Jan · Board meeting
To take on record the Audited Financial Results for the quarter and year ended December 31, 2010.
Oct 2010
7 Oct · Board meeting
To take on record the Unaudited Financial Results for the third quarter ended September 30, 2010.
Jul 2010
13 Jul · Board meeting
To take on record the Unaudited Financial Results for the Second quarter and half year ended June 30, 2010.
Apr 2010
8 Apr · Board meeting
Meeting on 23 Apr 2010: “Unaudited Financial Results for the qtr ended March 31, 2010”
Jan 2010
6 Jan · Board meeting
To take on record the Audited Financial Results and recommend dividend if any, for the year ended December 31, 2009.
Oct 2009
7 Oct · Board meeting
Meeting on 15 Oct 2009: “Unaudited Financial Results for the Qtr ended Sept 30, 2009”